FDANonrulemakingFDA-2022-D-2997

Who commented on this docket

Key Information and Facilitating Understanding in Informed Consent for FDA-Regulated Clinical Investigations; Draft Guidance for Sponsors, Clinical Investigators, and Institutional Review Boards; Availability

1 organizations filed 1 public comment on Key Information and Facilitating Understanding in Informed Consent for FDA-Regulated Clinical Investigations; Draft Guidance for Sponsors, Clinical Investigators, and Institutional Review Boards; Availability, at the Food and Drug Administration. The comment window closed 819d ago.

Organizations
1
Comments
1
RIN
Comment window
closed 819d ago

Abstract

OPEN

Commenters (1)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.